Adipose-Derived Stem Cells Modulate BV2 Microglial M1/M2 Polarization by Producing GDNF

Abstract

Neuroinflammation is associated with the pathogenesis of all types of neurological disease, in which microglial cells play a critical role. In response to disturbances in the microenvironment, microglia (MG) become activated and differentiate into either an M1 phenotype, which has a proinflammatory damaging effect, or an M2 phenotype, which plays an anti-inflammatory and reparative role. Thus, modulating microglial polarization is a suitable strategy to treat neuroinflammatory disorders. Glial cell-derived neurotrophic factor (GDNF) is a neurotrophic mediator that exerts neuroprotective effects during neurological diseases. In this study, we predicted that adipose-derived stem cells (ADSCs) could produce GDNF and investigated the effects of GDNF on microglial M1/M2 polarization. Furthermore, we determined whether GDNF modulates microglial activation and polarization via the phosphoinositide-3-kinase (PI3K)/AKT signaling pathway. We found that the secretion of inflammatory cytokines in lipopolysaccharide-stimulated MG was downregulated, whereas the antiinflammatory mediators in interleukin-4-stimulated MG were upregulated obviously, following pretreatment with ADSCs or GDNF. In addition, GDNF produced by ADSCs inhibited the MG M1 phenotype and promoted the M2 phenotype by upregulating the PI3K/ATK pathway. These results reveal that GDNF produced by ADSCs might be useful for the regulation of neuroinflammatory disorders.

Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6‐OHDA model of Parkinson's disease

“…Conversely, M2 microglia activation alleviates inflammatory response and promotes tissue repair by releasing the anti‐inflammatory cytokines include interleukin‐4 (IL‐4), IL‐10 and various trophic factors such as TGF‐β 59 . Recently, some increasing evidence has revealed that PI3K/Akt pathway plays an important role in microglial M1/M2 polarization via induction of M2‐type cell accumulation and the inhibition of M1‐type microglia production 60,61 . A study also showed that insulin treatment reduces the release of pro‐inflammatory cytokine TNF‐α 62 and induces an increase in the TGF‐β receptors at the cell surface which causes enhancement in the cell responsiveness to autocrine TGF‐β 63 .…”

Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation

“… 82 In addition, recruited monocytes might facilitate microglial M1/M2 polarization. 96 , 97 Microglia account for 10–15% of the total brain cells. They act as the main cell type in inflammatory response to phagocytose damaged cells and pathogens.…”

Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease

“…The transplanted stem cells can (a) inhibit microglial activation and neuroinflammation and (b) recruit peripheral monocytes across the blood-brain barrier into the lesion. These monocytes may switch the microglial M1/M2 phenotype to accelerate the removal of Aβ plaques in the AD brain [111][112][113] and (c) secret cytokines. Certain cytokines released by MSCs can facilitate cell survival and proliferation through the regulation of NGF, FGF2 and BDNF [46].…”